| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens, CD | 122 | 2024 | 4001 | 5.450 |
Why?
|
| CD8-Positive T-Lymphocytes | 81 | 2024 | 4580 | 5.400 |
Why?
|
| Lymphocyte Activation | 108 | 2024 | 5485 | 3.750 |
Why?
|
| Membrane Glycoproteins | 100 | 2018 | 3701 | 3.710 |
Why?
|
| T-Lymphocytes | 92 | 2024 | 10194 | 3.700 |
Why?
|
| T-Lymphocytes, Regulatory | 46 | 2024 | 3080 | 3.520 |
Why?
|
| Antigens, Differentiation | 51 | 2012 | 909 | 3.320 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 20 | 2019 | 974 | 3.070 |
Why?
|
| Autoimmunity | 27 | 2023 | 1356 | 3.050 |
Why?
|
| Immunotherapy | 31 | 2024 | 4652 | 2.730 |
Why?
|
| Autoimmune Diseases | 28 | 2024 | 2244 | 2.530 |
Why?
|
| Immune Tolerance | 39 | 2023 | 2302 | 2.520 |
Why?
|
| Lymphocytic choriomeningitis virus | 15 | 2024 | 177 | 2.450 |
Why?
|
| Germinal Center | 17 | 2022 | 380 | 2.250 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 18 | 2023 | 822 | 2.160 |
Why?
|
| Lymphocytic Choriomeningitis | 17 | 2024 | 139 | 2.040 |
Why?
|
| Immunoconjugates | 33 | 2003 | 953 | 1.980 |
Why?
|
| Mice, Knockout | 137 | 2024 | 14416 | 1.970 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 4 | 2023 | 51 | 1.830 |
Why?
|
| Mice | 324 | 2024 | 81533 | 1.760 |
Why?
|
| CD4-Positive T-Lymphocytes | 60 | 2023 | 4369 | 1.710 |
Why?
|
| Apoptosis Regulatory Proteins | 24 | 2013 | 1135 | 1.660 |
Why?
|
| B-Lymphocytes | 30 | 2023 | 4758 | 1.630 |
Why?
|
| Animals | 372 | 2024 | 168467 | 1.620 |
Why?
|
| Mice, Inbred C57BL | 136 | 2024 | 22172 | 1.540 |
Why?
|
| Peptides | 35 | 2022 | 4358 | 1.470 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 19 | 2012 | 898 | 1.440 |
Why?
|
| Neoplasms | 28 | 2024 | 22173 | 1.320 |
Why?
|
| Th2 Cells | 27 | 2024 | 1060 | 1.310 |
Why?
|
| Immune System Diseases | 3 | 2023 | 256 | 1.300 |
Why?
|
| Immunologic Memory | 17 | 2024 | 1359 | 1.290 |
Why?
|
| Receptors, Antigen, T-Cell | 24 | 2023 | 2547 | 1.270 |
Why?
|
| Mice, Inbred BALB C | 98 | 2021 | 6214 | 1.210 |
Why?
|
| Antigen-Presenting Cells | 24 | 2014 | 964 | 1.200 |
Why?
|
| Signal Transduction | 60 | 2024 | 23447 | 1.190 |
Why?
|
| Cell Differentiation | 50 | 2024 | 11530 | 1.180 |
Why?
|
| Antigens, Surface | 19 | 2011 | 1606 | 1.140 |
Why?
|
| Antibodies, Monoclonal | 37 | 2024 | 9177 | 1.060 |
Why?
|
| Receptors, Immunologic | 10 | 2023 | 1410 | 1.060 |
Why?
|
| Mice, Transgenic | 65 | 2019 | 9541 | 1.050 |
Why?
|
| Melanoma | 13 | 2024 | 5709 | 1.050 |
Why?
|
| Antibody Formation | 13 | 2020 | 1395 | 1.040 |
Why?
|
| T-Lymphocyte Subsets | 30 | 2022 | 1802 | 0.990 |
Why?
|
| Cytotoxicity, Immunologic | 10 | 2024 | 1351 | 0.910 |
Why?
|
| Self Tolerance | 5 | 2016 | 123 | 0.900 |
Why?
|
| Dendritic Cells | 22 | 2018 | 2747 | 0.880 |
Why?
|
| Immunity | 9 | 2022 | 996 | 0.880 |
Why?
|
| Tumor Microenvironment | 20 | 2023 | 3877 | 0.870 |
Why?
|
| Tumor Escape | 6 | 2017 | 370 | 0.850 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 11 | 2024 | 1092 | 0.850 |
Why?
|
| Leishmaniasis, Cutaneous | 8 | 2014 | 136 | 0.830 |
Why?
|
| Th1 Cells | 14 | 2024 | 1036 | 0.810 |
Why?
|
| Lymph Nodes | 16 | 2023 | 3466 | 0.770 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2020 | 83 | 0.690 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2019 | 20 | 0.670 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2020 | 254 | 0.670 |
Why?
|
| Autoantibodies | 9 | 2020 | 2116 | 0.660 |
Why?
|
| Immunity, Innate | 12 | 2023 | 3066 | 0.660 |
Why?
|
| Immunomodulation | 6 | 2019 | 549 | 0.630 |
Why?
|
| Arenaviridae Infections | 5 | 2017 | 53 | 0.620 |
Why?
|
| Diabetes Mellitus, Type 1 | 9 | 2023 | 3415 | 0.610 |
Why?
|
| Immunity, Humoral | 6 | 2019 | 606 | 0.610 |
Why?
|
| Melanoma, Experimental | 6 | 2024 | 560 | 0.610 |
Why?
|
| Forkhead Transcription Factors | 10 | 2023 | 1616 | 0.600 |
Why?
|
| Mice, Inbred NOD | 14 | 2023 | 1827 | 0.600 |
Why?
|
| T-Lymphocytes, Cytotoxic | 13 | 2011 | 1784 | 0.600 |
Why?
|
| Down-Regulation | 15 | 2023 | 2919 | 0.580 |
Why?
|
| Listeria monocytogenes | 2 | 2021 | 249 | 0.580 |
Why?
|
| Interleukin-4 | 15 | 2012 | 1149 | 0.570 |
Why?
|
| Communicable Diseases | 2 | 2021 | 875 | 0.570 |
Why?
|
| Cytokines | 43 | 2021 | 7396 | 0.570 |
Why?
|
| Antigen Presentation | 14 | 2023 | 1251 | 0.570 |
Why?
|
| Ligands | 23 | 2024 | 3272 | 0.560 |
Why?
|
| Blood Proteins | 6 | 2004 | 1173 | 0.550 |
Why?
|
| Interleukin-2 | 16 | 2024 | 1889 | 0.550 |
Why?
|
| Interferon-gamma | 23 | 2024 | 3162 | 0.550 |
Why?
|
| B-Lymphocyte Subsets | 3 | 2016 | 239 | 0.550 |
Why?
|
| Lymphocytes | 8 | 2021 | 2612 | 0.530 |
Why?
|
| Ovalbumin | 14 | 2022 | 677 | 0.510 |
Why?
|
| Adaptive Immunity | 3 | 2021 | 726 | 0.510 |
Why?
|
| Antibodies, Blocking | 14 | 2019 | 243 | 0.500 |
Why?
|
| Graft vs Host Disease | 13 | 2022 | 3029 | 0.490 |
Why?
|
| Gene Transfer Techniques | 3 | 2019 | 1206 | 0.480 |
Why?
|
| Leishmania major | 5 | 2014 | 59 | 0.470 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2021 | 1119 | 0.470 |
Why?
|
| Models, Immunological | 7 | 2010 | 513 | 0.460 |
Why?
|
| Cell Communication | 7 | 2014 | 1657 | 0.460 |
Why?
|
| DNA-Binding Proteins | 17 | 2024 | 9610 | 0.460 |
Why?
|
| Growth Inhibitors | 4 | 2011 | 378 | 0.450 |
Why?
|
| Alternative Splicing | 3 | 2012 | 1093 | 0.450 |
Why?
|
| Antigens | 10 | 2015 | 1443 | 0.450 |
Why?
|
| Immune System | 5 | 2023 | 796 | 0.450 |
Why?
|
| Tumor Cells, Cultured | 5 | 2020 | 6132 | 0.440 |
Why?
|
| Retroviridae Infections | 5 | 2002 | 147 | 0.440 |
Why?
|
| Interleukin-6 | 4 | 2022 | 3208 | 0.430 |
Why?
|
| Immunoglobulin Class Switching | 4 | 2014 | 289 | 0.430 |
Why?
|
| Liver Diseases | 1 | 2022 | 1298 | 0.430 |
Why?
|
| Cells, Cultured | 40 | 2019 | 18965 | 0.420 |
Why?
|
| Killer Cells, Natural | 9 | 2024 | 2201 | 0.420 |
Why?
|
| Disease Models, Animal | 31 | 2024 | 18253 | 0.420 |
Why?
|
| Cell Line, Tumor | 21 | 2024 | 16986 | 0.420 |
Why?
|
| Humans | 152 | 2024 | 761572 | 0.410 |
Why?
|
| Haploinsufficiency | 1 | 2014 | 337 | 0.410 |
Why?
|
| Reoviridae | 14 | 1987 | 162 | 0.410 |
Why?
|
| Interleukins | 7 | 2016 | 782 | 0.410 |
Why?
|
| Adoptive Transfer | 15 | 2016 | 819 | 0.410 |
Why?
|
| Flow Cytometry | 27 | 2023 | 5869 | 0.400 |
Why?
|
| Gene Expression Regulation | 19 | 2024 | 11904 | 0.400 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2023 | 5305 | 0.400 |
Why?
|
| Immunity, Mucosal | 3 | 2018 | 483 | 0.390 |
Why?
|
| Spleen | 21 | 2018 | 2295 | 0.380 |
Why?
|
| Viral Envelope Proteins | 3 | 2020 | 640 | 0.380 |
Why?
|
| Immunoassay | 1 | 2015 | 745 | 0.370 |
Why?
|
| Bone Marrow Transplantation | 13 | 2019 | 2693 | 0.370 |
Why?
|
| Colonic Neoplasms | 2 | 2021 | 2538 | 0.370 |
Why?
|
| Glomerulonephritis | 4 | 2011 | 331 | 0.370 |
Why?
|
| Graft Rejection | 16 | 2017 | 4446 | 0.370 |
Why?
|
| Interleukin-10 | 12 | 2022 | 1175 | 0.370 |
Why?
|
| Lupus Erythematosus, Systemic | 8 | 2013 | 2155 | 0.360 |
Why?
|
| Bronchiolitis Obliterans | 3 | 2022 | 213 | 0.350 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 5 | 2022 | 799 | 0.350 |
Why?
|
| Antigens, Neoplasm | 6 | 2023 | 1993 | 0.350 |
Why?
|
| Myocarditis | 6 | 2021 | 788 | 0.350 |
Why?
|
| Receptors, Tumor Necrosis Factor | 5 | 2009 | 585 | 0.350 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2020 | 1469 | 0.340 |
Why?
|
| Hematopoietic Stem Cells | 6 | 2016 | 3397 | 0.340 |
Why?
|
| Macrophages, Peritoneal | 3 | 2022 | 238 | 0.340 |
Why?
|
| Epigenesis, Genetic | 5 | 2024 | 3801 | 0.330 |
Why?
|
| Clonal Deletion | 3 | 2019 | 74 | 0.320 |
Why?
|
| Molecular Sequence Data | 36 | 2015 | 17635 | 0.320 |
Why?
|
| Carcinoma, Renal Cell | 5 | 2024 | 3165 | 0.320 |
Why?
|
| Heart Transplantation | 15 | 2021 | 3233 | 0.320 |
Why?
|
| Listeriosis | 2 | 2021 | 149 | 0.310 |
Why?
|
| Endogenous Retroviruses | 2 | 2020 | 111 | 0.310 |
Why?
|
| Lymphocyte Count | 6 | 2016 | 778 | 0.310 |
Why?
|
| Disease Susceptibility | 5 | 2019 | 1787 | 0.300 |
Why?
|
| Cell Proliferation | 23 | 2024 | 10448 | 0.300 |
Why?
|
| Adenocarcinoma | 3 | 2021 | 6346 | 0.300 |
Why?
|
| Homeostasis | 11 | 2022 | 3323 | 0.300 |
Why?
|
| Lymphoproliferative Disorders | 6 | 2009 | 531 | 0.290 |
Why?
|
| Malaria, Falciparum | 2 | 2016 | 1077 | 0.290 |
Why?
|
| Germ-Line Mutation | 3 | 2014 | 1858 | 0.290 |
Why?
|
| Amino Acid Sequence | 26 | 2015 | 13446 | 0.290 |
Why?
|
| Cell Lineage | 5 | 2022 | 2556 | 0.290 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 2024 | 1349 | 0.290 |
Why?
|
| Kidney Neoplasms | 5 | 2023 | 4251 | 0.280 |
Why?
|
| Skin Neoplasms | 5 | 2021 | 5821 | 0.280 |
Why?
|
| Gammaretrovirus | 2 | 2000 | 24 | 0.280 |
Why?
|
| Molecular Targeted Therapy | 2 | 2018 | 2811 | 0.280 |
Why?
|
| Genetic Testing | 2 | 2021 | 3537 | 0.280 |
Why?
|
| Receptors, Cell Surface | 5 | 2013 | 2822 | 0.270 |
Why?
|
| Lymphoid Tissue | 7 | 2006 | 445 | 0.270 |
Why?
|
| Stromal Cells | 4 | 2022 | 1330 | 0.270 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 11 | 2017 | 3810 | 0.270 |
Why?
|
| Aging | 6 | 2024 | 8711 | 0.270 |
Why?
|
| Calcineurin | 2 | 2024 | 229 | 0.270 |
Why?
|
| Plasmodium falciparum | 2 | 2016 | 1742 | 0.260 |
Why?
|
| Retroviridae | 7 | 1999 | 850 | 0.260 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 3 | 2023 | 263 | 0.260 |
Why?
|
| Glioblastoma | 4 | 2023 | 3482 | 0.260 |
Why?
|
| Mice, Inbred Strains | 11 | 2014 | 1762 | 0.260 |
Why?
|
| Exons | 7 | 2011 | 2391 | 0.250 |
Why?
|
| Encephalopathy, Bovine Spongiform | 1 | 2004 | 6 | 0.250 |
Why?
|
| Sheep Diseases | 1 | 2004 | 18 | 0.250 |
Why?
|
| Asthma | 9 | 2022 | 6234 | 0.250 |
Why?
|
| PrPSc Proteins | 1 | 2004 | 32 | 0.240 |
Why?
|
| Immunoglobulins | 4 | 2024 | 852 | 0.240 |
Why?
|
| Central Nervous System Diseases | 5 | 2011 | 520 | 0.240 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily D | 1 | 2024 | 30 | 0.240 |
Why?
|
| Graft Survival | 12 | 2015 | 3820 | 0.240 |
Why?
|
| Leishmania mexicana | 3 | 2014 | 33 | 0.240 |
Why?
|
| Adjuvants, Immunologic | 6 | 2014 | 1036 | 0.230 |
Why?
|
| Fibrinogen | 2 | 2020 | 888 | 0.230 |
Why?
|
| Formates | 1 | 2023 | 40 | 0.230 |
Why?
|
| OX40 Ligand | 7 | 2014 | 55 | 0.230 |
Why?
|
| Genome | 1 | 2012 | 1740 | 0.230 |
Why?
|
| Protein Binding | 9 | 2024 | 9353 | 0.230 |
Why?
|
| Transplantation Tolerance | 4 | 2013 | 605 | 0.220 |
Why?
|
| Interferon Type I | 4 | 2023 | 562 | 0.220 |
Why?
|
| Glycerol-3-Phosphate Dehydrogenase (NAD+) | 1 | 2023 | 11 | 0.220 |
Why?
|
| Endoplasmic Reticulum | 2 | 2020 | 1134 | 0.220 |
Why?
|
| Multiple Sclerosis | 3 | 2016 | 3220 | 0.210 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2007 | 1651 | 0.210 |
Why?
|
| Colorectal Neoplasms | 5 | 2023 | 6935 | 0.210 |
Why?
|
| Administration, Intranasal | 2 | 2020 | 477 | 0.210 |
Why?
|
| Hepatic Stellate Cells | 2 | 2022 | 119 | 0.210 |
Why?
|
| Friends | 1 | 2024 | 149 | 0.210 |
Why?
|
| Germ-Free Life | 1 | 2023 | 189 | 0.210 |
Why?
|
| Mice, Mutant Strains | 18 | 2019 | 1749 | 0.210 |
Why?
|
| Receptors, CXCR3 | 2 | 2014 | 238 | 0.210 |
Why?
|
| Immunization | 5 | 2015 | 1227 | 0.210 |
Why?
|
| Antineoplastic Agents | 4 | 2020 | 13642 | 0.210 |
Why?
|
| Toxoplasmosis, Animal | 1 | 2022 | 18 | 0.200 |
Why?
|
| Gene Knockout Techniques | 2 | 2024 | 802 | 0.200 |
Why?
|
| Species Specificity | 6 | 2020 | 2414 | 0.200 |
Why?
|
| Th17 Cells | 3 | 2015 | 794 | 0.200 |
Why?
|
| Female | 90 | 2024 | 392686 | 0.200 |
Why?
|
| Maternal-Fetal Exchange | 5 | 2013 | 461 | 0.200 |
Why?
|
| Chronic Disease | 12 | 2022 | 9319 | 0.200 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2024 | 323 | 0.200 |
Why?
|
| Thymus Gland | 10 | 2009 | 1243 | 0.200 |
Why?
|
| Immunohistochemistry | 10 | 2019 | 11076 | 0.190 |
Why?
|
| Brassica | 3 | 1998 | 39 | 0.190 |
Why?
|
| DNA Helicases | 2 | 2024 | 851 | 0.190 |
Why?
|
| Immunoglobulin G | 12 | 2019 | 4544 | 0.190 |
Why?
|
| Glycoproteins | 3 | 2005 | 2203 | 0.190 |
Why?
|
| Virus Diseases | 4 | 2010 | 718 | 0.190 |
Why?
|
| Proteins | 10 | 2022 | 6032 | 0.190 |
Why?
|
| Pyruvic Acid | 1 | 2022 | 204 | 0.190 |
Why?
|
| Monocytes | 3 | 2022 | 2570 | 0.190 |
Why?
|
| Complementarity Determining Regions | 2 | 2022 | 149 | 0.190 |
Why?
|
| Up-Regulation | 15 | 2015 | 4124 | 0.190 |
Why?
|
| Precursor Cells, T-Lymphoid | 1 | 2021 | 19 | 0.190 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2021 | 107 | 0.190 |
Why?
|
| Glutarates | 1 | 2022 | 243 | 0.180 |
Why?
|
| Apoptosis | 16 | 2016 | 9489 | 0.180 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2021 | 93 | 0.180 |
Why?
|
| Pancreas | 2 | 2023 | 1691 | 0.180 |
Why?
|
| Clonal Anergy | 1 | 2001 | 169 | 0.180 |
Why?
|
| Immunoglobulin M | 5 | 2018 | 1526 | 0.170 |
Why?
|
| Myofibroblasts | 1 | 2022 | 223 | 0.170 |
Why?
|
| Ebolavirus | 1 | 2022 | 251 | 0.170 |
Why?
|
| Lung | 12 | 2022 | 10002 | 0.170 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2021 | 200 | 0.170 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2000 | 93 | 0.170 |
Why?
|
| Leukopoiesis | 2 | 1998 | 54 | 0.170 |
Why?
|
| Fibroblasts | 6 | 2019 | 4141 | 0.170 |
Why?
|
| Macrophages | 10 | 2022 | 5769 | 0.170 |
Why?
|
| Lupus Nephritis | 4 | 2011 | 317 | 0.170 |
Why?
|
| Mice, SCID | 7 | 2016 | 2626 | 0.170 |
Why?
|
| Epitopes, T-Lymphocyte | 9 | 2012 | 828 | 0.170 |
Why?
|
| Zidovudine | 6 | 1993 | 624 | 0.160 |
Why?
|
| GPI-Linked Proteins | 2 | 2018 | 470 | 0.160 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2019 | 39 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-maf | 2 | 2009 | 69 | 0.160 |
Why?
|
| Receptors, OX40 | 4 | 2014 | 44 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2021 | 2872 | 0.160 |
Why?
|
| Isocitrate Dehydrogenase | 2 | 2022 | 938 | 0.160 |
Why?
|
| Histone Demethylases | 2 | 2020 | 323 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2021 | 4352 | 0.160 |
Why?
|
| HLA-B7 Antigen | 1 | 1998 | 48 | 0.160 |
Why?
|
| Integrases | 1 | 2021 | 518 | 0.160 |
Why?
|
| Herpes Simplex | 2 | 2014 | 478 | 0.160 |
Why?
|
| Cricetinae | 7 | 2012 | 2423 | 0.160 |
Why?
|
| Transcription, Genetic | 5 | 2021 | 7593 | 0.160 |
Why?
|
| Peptide Fragments | 8 | 2009 | 5112 | 0.160 |
Why?
|
| Viruses | 1 | 2022 | 375 | 0.160 |
Why?
|
| CD40 Ligand | 8 | 2008 | 522 | 0.160 |
Why?
|
| Transplantation Chimera | 2 | 2019 | 594 | 0.160 |
Why?
|
| Hypersensitivity | 4 | 2019 | 1171 | 0.160 |
Why?
|
| Genes, Viral | 7 | 1991 | 649 | 0.160 |
Why?
|
| Transplantation, Homologous | 12 | 2017 | 4807 | 0.160 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2021 | 2865 | 0.160 |
Why?
|
| Gene Deletion | 6 | 2020 | 2665 | 0.160 |
Why?
|
| Receptor Cross-Talk | 2 | 2016 | 116 | 0.150 |
Why?
|
| Citrobacter rodentium | 1 | 2018 | 65 | 0.150 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2018 | 56 | 0.150 |
Why?
|
| CHO Cells | 6 | 2012 | 1387 | 0.150 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2020 | 899 | 0.150 |
Why?
|
| Extinction, Psychological | 1 | 2001 | 371 | 0.150 |
Why?
|
| Vero Cells | 1 | 2019 | 482 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2018 | 191 | 0.150 |
Why?
|
| Osteoclasts | 1 | 2022 | 711 | 0.150 |
Why?
|
| Cell Cycle | 4 | 2003 | 2932 | 0.150 |
Why?
|
| Cell Division | 10 | 2002 | 4465 | 0.150 |
Why?
|
| Alleles | 4 | 2022 | 6864 | 0.150 |
Why?
|
| Natural Killer T-Cells | 2 | 2013 | 322 | 0.150 |
Why?
|
| Receptors, Interleukin-2 | 6 | 2006 | 562 | 0.150 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2020 | 507 | 0.150 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2022 | 420 | 0.150 |
Why?
|
| Plasma Cells | 2 | 2012 | 599 | 0.150 |
Why?
|
| Mice, Congenic | 3 | 2019 | 97 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2021 | 2456 | 0.140 |
Why?
|
| Interleukin-21 Receptor alpha Subunit | 1 | 2016 | 18 | 0.140 |
Why?
|
| Gene Expression | 9 | 2019 | 7581 | 0.140 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2016 | 832 | 0.140 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1996 | 74 | 0.140 |
Why?
|
| Respiratory Hypersensitivity | 2 | 2014 | 273 | 0.140 |
Why?
|
| Herpesvirus 1, Human | 2 | 2014 | 753 | 0.140 |
Why?
|
| Lymphocyte Depletion | 5 | 2017 | 602 | 0.140 |
Why?
|
| Alanine | 1 | 2019 | 609 | 0.140 |
Why?
|
| Immunoglobulin Idiotypes | 3 | 1986 | 200 | 0.140 |
Why?
|
| Receptors, Virus | 5 | 2011 | 640 | 0.140 |
Why?
|
| Colitis | 4 | 2011 | 1233 | 0.140 |
Why?
|
| RNA, Messenger | 17 | 2012 | 12794 | 0.140 |
Why?
|
| STAT6 Transcription Factor | 5 | 2004 | 194 | 0.140 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2016 | 93 | 0.140 |
Why?
|
| Mammalian orthoreovirus 3 | 8 | 1986 | 45 | 0.130 |
Why?
|
| Golgi Apparatus | 1 | 2018 | 405 | 0.130 |
Why?
|
| Peyer's Patches | 4 | 2015 | 120 | 0.130 |
Why?
|
| Neoplasm Proteins | 3 | 2019 | 3617 | 0.130 |
Why?
|
| Selenoproteins | 1 | 2018 | 215 | 0.130 |
Why?
|
| Carbon | 2 | 2018 | 666 | 0.130 |
Why?
|
| Cell Membrane | 2 | 2016 | 3687 | 0.130 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2018 | 188 | 0.130 |
Why?
|
| RNA | 5 | 2022 | 2726 | 0.130 |
Why?
|
| Brain Edema | 1 | 2020 | 604 | 0.130 |
Why?
|
| Reoviridae Infections | 6 | 1990 | 59 | 0.130 |
Why?
|
| Liver Neoplasms | 2 | 2022 | 4319 | 0.130 |
Why?
|
| Base Sequence | 17 | 2004 | 12441 | 0.130 |
Why?
|
| Gene Products, gag | 1 | 1996 | 312 | 0.130 |
Why?
|
| Protein Multimerization | 1 | 2021 | 983 | 0.130 |
Why?
|
| Viral Vaccines | 3 | 2014 | 596 | 0.130 |
Why?
|
| Immunosuppressive Agents | 8 | 2011 | 4176 | 0.130 |
Why?
|
| Schistosomiasis mansoni | 2 | 2011 | 93 | 0.130 |
Why?
|
| RNA Virus Infections | 1 | 2015 | 19 | 0.130 |
Why?
|
| Receptors, CCR | 2 | 2013 | 37 | 0.130 |
Why?
|
| RNA, Viral | 9 | 2013 | 2846 | 0.130 |
Why?
|
| Behavior, Addictive | 1 | 2001 | 462 | 0.130 |
Why?
|
| Cloning, Molecular | 10 | 2004 | 4174 | 0.130 |
Why?
|
| Endothelial Cells | 6 | 2021 | 3548 | 0.130 |
Why?
|
| Plant Proteins | 2 | 1996 | 370 | 0.130 |
Why?
|
| Cell Separation | 4 | 2015 | 1720 | 0.130 |
Why?
|
| Prion Diseases | 1 | 1996 | 100 | 0.130 |
Why?
|
| Autoantigens | 4 | 2019 | 891 | 0.130 |
Why?
|
| Medical Staff, Hospital | 1 | 2019 | 601 | 0.130 |
Why?
|
| Viscera | 1 | 1995 | 138 | 0.120 |
Why?
|
| Haptens | 3 | 2001 | 163 | 0.120 |
Why?
|
| Influenza A virus | 3 | 2014 | 458 | 0.120 |
Why?
|
| Genomic Islands | 1 | 2015 | 52 | 0.120 |
Why?
|
| HEK293 Cells | 3 | 2020 | 4280 | 0.120 |
Why?
|
| Cell Line | 12 | 2021 | 15601 | 0.120 |
Why?
|
| Cell Death | 1 | 2020 | 1679 | 0.120 |
Why?
|
| Retinal Ganglion Cells | 2 | 2012 | 811 | 0.120 |
Why?
|
| Cell Culture Techniques | 3 | 2022 | 1667 | 0.120 |
Why?
|
| Acyl Coenzyme A | 1 | 1994 | 56 | 0.120 |
Why?
|
| Emulsions | 1 | 2015 | 152 | 0.120 |
Why?
|
| Silicones | 1 | 2015 | 228 | 0.120 |
Why?
|
| Mice, Inbred MRL lpr | 7 | 2013 | 153 | 0.120 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2014 | 151 | 0.120 |
Why?
|
| Lymphocyte Culture Test, Mixed | 5 | 2001 | 509 | 0.120 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 2 | 2013 | 117 | 0.120 |
Why?
|
| Microtubules | 3 | 2013 | 1074 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 1229 | 0.110 |
Why?
|
| NFATC Transcription Factors | 4 | 2024 | 389 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 3 | 2021 | 174 | 0.110 |
Why?
|
| Immunity, Cellular | 6 | 2018 | 1560 | 0.110 |
Why?
|
| Leukemia | 1 | 2022 | 1522 | 0.110 |
Why?
|
| Tumor Necrosis Factors | 6 | 2004 | 107 | 0.110 |
Why?
|
| Lipids | 2 | 2023 | 3341 | 0.110 |
Why?
|
| Antigens, Helminth | 2 | 2011 | 68 | 0.110 |
Why?
|
| Phenotype | 11 | 2021 | 16592 | 0.110 |
Why?
|
| Mice, 129 Strain | 2 | 2011 | 371 | 0.110 |
Why?
|
| Interleukin-23 | 2 | 2012 | 201 | 0.110 |
Why?
|
| Sequence Analysis, RNA | 2 | 2020 | 2020 | 0.110 |
Why?
|
| Interleukin-17 | 4 | 2012 | 912 | 0.110 |
Why?
|
| Recombination, Genetic | 6 | 2014 | 1519 | 0.110 |
Why?
|
| Carboxy-Lyases | 1 | 2013 | 85 | 0.110 |
Why?
|
| Pneumonia | 2 | 2019 | 2143 | 0.110 |
Why?
|
| Dexamethasone | 1 | 2020 | 1948 | 0.110 |
Why?
|
| Nematospiroides dubius | 3 | 2003 | 37 | 0.110 |
Why?
|
| Rodent Diseases | 1 | 1993 | 53 | 0.110 |
Why?
|
| Male | 47 | 2024 | 360842 | 0.110 |
Why?
|
| Enterotoxins | 3 | 2004 | 366 | 0.110 |
Why?
|
| Small Molecule Libraries | 1 | 2018 | 733 | 0.110 |
Why?
|
| Apyrase | 1 | 2015 | 373 | 0.110 |
Why?
|
| Conserved Sequence | 4 | 2012 | 1163 | 0.100 |
Why?
|
| Autophagy | 1 | 2020 | 1326 | 0.100 |
Why?
|
| Bronchial Hyperreactivity | 3 | 2008 | 302 | 0.100 |
Why?
|
| Cell Survival | 7 | 2019 | 5791 | 0.100 |
Why?
|
| Carrier Proteins | 4 | 2009 | 4937 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 1334 | 0.100 |
Why?
|
| Atherosclerosis | 4 | 2011 | 3408 | 0.100 |
Why?
|
| Transplantation Immunology | 2 | 2005 | 532 | 0.100 |
Why?
|
| Intestinal Diseases, Parasitic | 2 | 2003 | 64 | 0.100 |
Why?
|
| Founder Effect | 1 | 2013 | 186 | 0.100 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2012 | 69 | 0.100 |
Why?
|
| Motor Neuron Disease | 1 | 1993 | 97 | 0.100 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 2450 | 0.100 |
Why?
|
| Mitochondrial Proteins | 2 | 2013 | 976 | 0.100 |
Why?
|
| Genes, Plant | 3 | 1998 | 128 | 0.100 |
Why?
|
| Blotting, Southern | 4 | 2014 | 777 | 0.100 |
Why?
|
| Chromosome Mapping | 5 | 1997 | 4615 | 0.100 |
Why?
|
| Mitochondria | 5 | 2021 | 3624 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2021 | 2898 | 0.100 |
Why?
|
| Cell Surface Extensions | 1 | 2012 | 67 | 0.100 |
Why?
|
| Organ Specificity | 3 | 2017 | 1968 | 0.100 |
Why?
|
| Teaching | 1 | 2019 | 1170 | 0.100 |
Why?
|
| Cross-Priming | 2 | 2012 | 76 | 0.100 |
Why?
|
| RNA Splice Sites | 1 | 2013 | 211 | 0.100 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2017 | 572 | 0.100 |
Why?
|
| Enteritis | 2 | 2012 | 162 | 0.100 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 2 | 2022 | 86 | 0.100 |
Why?
|
| Transcription Factors | 9 | 2020 | 12129 | 0.100 |
Why?
|
| High Mobility Group Proteins | 2 | 2024 | 177 | 0.100 |
Why?
|
| Helicobacter pylori | 1 | 2015 | 377 | 0.100 |
Why?
|
| Interleukin-1beta | 3 | 2012 | 999 | 0.100 |
Why?
|
| Microglia | 2 | 1999 | 1361 | 0.100 |
Why?
|
| Gene Targeting | 7 | 2001 | 838 | 0.100 |
Why?
|
| Genetic Vectors | 3 | 2019 | 3396 | 0.100 |
Why?
|
| Cell Movement | 11 | 2022 | 5205 | 0.100 |
Why?
|
| Immune Evasion | 1 | 2015 | 363 | 0.100 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 1935 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2013 | 4575 | 0.090 |
Why?
|
| Inbreeding | 1 | 2011 | 48 | 0.090 |
Why?
|
| Immunoglobulin E | 7 | 2019 | 1502 | 0.090 |
Why?
|
| Muscle Cells | 1 | 2012 | 195 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2021 | 2057 | 0.090 |
Why?
|
| Immunophenotyping | 5 | 2017 | 1869 | 0.090 |
Why?
|
| Transfection | 7 | 2012 | 5774 | 0.090 |
Why?
|
| Interleukin-3 | 1 | 2012 | 425 | 0.090 |
Why?
|
| Interphase | 2 | 2002 | 228 | 0.090 |
Why?
|
| Tamoxifen | 1 | 2015 | 965 | 0.090 |
Why?
|
| Trans-Activators | 6 | 2004 | 2856 | 0.090 |
Why?
|
| Vaccines, Synthetic | 4 | 2014 | 616 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2021 | 1909 | 0.090 |
Why?
|
| Inflammation | 11 | 2022 | 10773 | 0.090 |
Why?
|
| Cochlear Implants | 1 | 2015 | 339 | 0.090 |
Why?
|
| Helminth Proteins | 1 | 2011 | 173 | 0.090 |
Why?
|
| Gene Expression Profiling | 7 | 2017 | 9420 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2023 | 3415 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 8552 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2023 | 11742 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2020 | 2468 | 0.090 |
Why?
|
| Schistosoma mansoni | 1 | 2011 | 155 | 0.090 |
Why?
|
| Central Nervous System | 4 | 2003 | 1336 | 0.090 |
Why?
|
| Strongylida Infections | 4 | 2003 | 48 | 0.090 |
Why?
|
| Sirtuins | 1 | 2013 | 320 | 0.090 |
Why?
|
| Brain Neoplasms | 3 | 2022 | 9031 | 0.090 |
Why?
|
| Tumor Burden | 3 | 2023 | 1893 | 0.090 |
Why?
|
| Genetic Linkage | 4 | 2008 | 2341 | 0.090 |
Why?
|
| Myeloid Cells | 3 | 2021 | 823 | 0.090 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 585 | 0.090 |
Why?
|
| Electric Stimulation | 1 | 2015 | 1736 | 0.090 |
Why?
|
| Islets of Langerhans | 2 | 2009 | 1341 | 0.090 |
Why?
|
| Tuberous Sclerosis | 1 | 2018 | 1030 | 0.090 |
Why?
|
| Trigeminal Ganglion | 1 | 2011 | 190 | 0.090 |
Why?
|
| Retina | 2 | 2012 | 2659 | 0.090 |
Why?
|
| MicroRNAs | 3 | 2017 | 3816 | 0.090 |
Why?
|
| Granulocytes | 1 | 2011 | 551 | 0.080 |
Why?
|
| Pneumococcal Infections | 1 | 2014 | 501 | 0.080 |
Why?
|
| Prognosis | 6 | 2020 | 29629 | 0.080 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2023 | 2057 | 0.080 |
Why?
|
| Crosses, Genetic | 9 | 2007 | 749 | 0.080 |
Why?
|
| Age Factors | 4 | 2024 | 18398 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2007 | 2748 | 0.080 |
Why?
|
| Mast-Cell Sarcoma | 2 | 1999 | 46 | 0.080 |
Why?
|
| Hypersensitivity, Delayed | 4 | 2009 | 490 | 0.080 |
Why?
|
| Oxidation-Reduction | 3 | 2023 | 2231 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2015 | 2425 | 0.080 |
Why?
|
| Immune Sera | 4 | 2007 | 606 | 0.080 |
Why?
|
| Vaccines, DNA | 2 | 2000 | 286 | 0.080 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2013 | 445 | 0.080 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 8528 | 0.080 |
Why?
|
| Antigens, T-Independent | 2 | 1999 | 21 | 0.080 |
Why?
|
| Genomics | 3 | 2020 | 5821 | 0.080 |
Why?
|
| Dermatitis, Contact | 2 | 1999 | 133 | 0.080 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 2 | 2022 | 25 | 0.080 |
Why?
|
| Streptococcus pneumoniae | 1 | 2014 | 730 | 0.080 |
Why?
|
| Hepatitis C, Chronic | 2 | 2015 | 1032 | 0.080 |
Why?
|
| Uveitis, Posterior | 1 | 2009 | 45 | 0.080 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2023 | 545 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2016 | 17904 | 0.080 |
Why?
|
| Epitopes | 4 | 2021 | 2503 | 0.080 |
Why?
|
| Intestinal Mucosa | 6 | 2013 | 3032 | 0.080 |
Why?
|
| Mice, Inbred C3H | 5 | 2015 | 915 | 0.080 |
Why?
|
| Histocompatibility Antigens Class II | 6 | 2020 | 1435 | 0.080 |
Why?
|
| Leukemia, Experimental | 1 | 1989 | 225 | 0.080 |
Why?
|
| Muscle Proteins | 3 | 2003 | 1154 | 0.080 |
Why?
|
| Alcohol Drinking | 1 | 2001 | 4028 | 0.080 |
Why?
|
| Disease Management | 1 | 2019 | 2508 | 0.080 |
Why?
|
| Graft Enhancement, Immunologic | 2 | 2007 | 57 | 0.080 |
Why?
|
| Liver | 8 | 2014 | 7529 | 0.080 |
Why?
|
| Surgical Procedures, Operative | 1 | 2019 | 1924 | 0.080 |
Why?
|
| Interleukin-12 | 2 | 2008 | 584 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5247 | 0.080 |
Why?
|
| Virus Latency | 1 | 2011 | 363 | 0.070 |
Why?
|
| Blotting, Western | 7 | 2016 | 5035 | 0.070 |
Why?
|
| Cell Transformation, Viral | 3 | 1989 | 526 | 0.070 |
Why?
|
| Bone Marrow Cells | 7 | 2016 | 2417 | 0.070 |
Why?
|
| Melanocytes | 3 | 2021 | 509 | 0.070 |
Why?
|
| DNA Primers | 6 | 2014 | 2819 | 0.070 |
Why?
|
| Membrane Proteins | 7 | 2007 | 7858 | 0.070 |
Why?
|
| Antiviral Agents | 3 | 1991 | 3060 | 0.070 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 435 | 0.070 |
Why?
|
| Phosphorylation | 5 | 2021 | 8321 | 0.070 |
Why?
|
| Placenta | 2 | 2013 | 1709 | 0.070 |
Why?
|
| Thymidine | 1 | 1987 | 299 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2009 | 3612 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 2 | 2024 | 4415 | 0.070 |
Why?
|
| Toll-Like Receptors | 2 | 2008 | 589 | 0.070 |
Why?
|
| Protein Isoforms | 4 | 2011 | 1699 | 0.070 |
Why?
|
| Cancer Vaccines | 1 | 2014 | 1051 | 0.070 |
Why?
|
| DNA, Complementary | 5 | 1997 | 1991 | 0.070 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2007 | 106 | 0.070 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2009 | 662 | 0.070 |
Why?
|
| Antibodies, Anti-Idiotypic | 2 | 1986 | 357 | 0.070 |
Why?
|
| Embryo, Mammalian | 7 | 2001 | 1674 | 0.070 |
Why?
|
| Superantigens | 2 | 2004 | 126 | 0.070 |
Why?
|
| Sequence Deletion | 3 | 2012 | 1494 | 0.070 |
Why?
|
| Keratitis | 1 | 2009 | 241 | 0.070 |
Why?
|
| Cytoskeleton | 2 | 1982 | 1170 | 0.070 |
Why?
|
| Phosphatidylserines | 1 | 2007 | 188 | 0.070 |
Why?
|
| Chemokines | 4 | 2021 | 959 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2022 | 3763 | 0.070 |
Why?
|
| Specific Pathogen-Free Organisms | 3 | 2017 | 221 | 0.070 |
Why?
|
| Fetal Diseases | 2 | 1993 | 913 | 0.070 |
Why?
|
| Injections, Intravenous | 2 | 2005 | 1379 | 0.070 |
Why?
|
| Proteome | 1 | 2016 | 1862 | 0.070 |
Why?
|
| Virus Replication | 6 | 2013 | 2435 | 0.070 |
Why?
|
| Curriculum | 1 | 2019 | 3743 | 0.070 |
Why?
|
| RNA Interference | 1 | 2014 | 2832 | 0.070 |
Why?
|
| Stem Cells | 8 | 2000 | 3523 | 0.070 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 2 | 2022 | 306 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2016 | 4243 | 0.060 |
Why?
|
| Bacterial Toxins | 2 | 2002 | 932 | 0.060 |
Why?
|
| Chromatin | 3 | 2018 | 2961 | 0.060 |
Why?
|
| Mice, Inbred CBA | 3 | 2013 | 436 | 0.060 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2005 | 51 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 2 | 2012 | 1962 | 0.060 |
Why?
|
| Antigens, CD1 | 1 | 2008 | 439 | 0.060 |
Why?
|
| Myelin Proteins | 2 | 2012 | 209 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2020 | 10766 | 0.060 |
Why?
|
| Endothelium, Vascular | 2 | 2011 | 4431 | 0.060 |
Why?
|
| Immunization, Secondary | 4 | 2004 | 367 | 0.060 |
Why?
|
| Moloney murine leukemia virus | 3 | 1991 | 109 | 0.060 |
Why?
|
| Calcium Signaling | 2 | 2012 | 733 | 0.060 |
Why?
|
| Virulence | 3 | 2014 | 1303 | 0.060 |
Why?
|
| Transcriptional Activation | 2 | 2009 | 1756 | 0.060 |
Why?
|
| Coculture Techniques | 4 | 2016 | 1341 | 0.060 |
Why?
|
| Receptor Activity-Modifying Protein 3 | 1 | 2024 | 7 | 0.060 |
Why?
|
| Integrin alpha Chains | 1 | 2005 | 95 | 0.060 |
Why?
|
| Antigens, Viral | 5 | 1990 | 988 | 0.060 |
Why?
|
| Calcitonin Receptor-Like Protein | 1 | 2024 | 13 | 0.060 |
Why?
|
| Receptors, Nerve Growth Factor | 2 | 2004 | 198 | 0.060 |
Why?
|
| Acute Disease | 3 | 2013 | 7237 | 0.060 |
Why?
|
| Interleukin-13 | 2 | 2019 | 392 | 0.060 |
Why?
|
| Dry Eye Syndromes | 1 | 2009 | 387 | 0.060 |
Why?
|
| Exosomes | 1 | 2009 | 424 | 0.060 |
Why?
|
| Bone Marrow | 3 | 2011 | 2911 | 0.060 |
Why?
|
| Nephrotic Syndrome | 2 | 2004 | 390 | 0.060 |
Why?
|
| Transplantation, Heterotopic | 1 | 2005 | 174 | 0.060 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily C | 1 | 2024 | 35 | 0.060 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 13382 | 0.060 |
Why?
|
| Ireland | 1 | 2004 | 170 | 0.060 |
Why?
|
| Energy Metabolism | 3 | 2022 | 2882 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2017 | 2781 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 1902 | 0.060 |
Why?
|
| Nerve Growth Factors | 2 | 2021 | 564 | 0.060 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2000 | 1126 | 0.060 |
Why?
|
| Tumor Virus Infections | 1 | 1987 | 438 | 0.060 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2024 | 59 | 0.060 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2016 | 1914 | 0.060 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2005 | 157 | 0.060 |
Why?
|
| Transduction, Genetic | 3 | 2014 | 903 | 0.060 |
Why?
|
| DNA | 10 | 2004 | 7213 | 0.060 |
Why?
|
| Malaria | 1 | 2013 | 1227 | 0.060 |
Why?
|
| Dose-Response Relationship, Immunologic | 3 | 2000 | 364 | 0.060 |
Why?
|
| Immunoglobulin Isotypes | 2 | 2001 | 158 | 0.060 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2016 | 755 | 0.060 |
Why?
|
| Autocrine Communication | 1 | 2024 | 169 | 0.060 |
Why?
|
| Models, Animal | 2 | 2008 | 2112 | 0.060 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 2023 | 37 | 0.050 |
Why?
|
| Corneal Transplantation | 1 | 2007 | 321 | 0.050 |
Why?
|
| Tissue Distribution | 5 | 2005 | 2264 | 0.050 |
Why?
|
| Phagocytosis | 2 | 2007 | 1528 | 0.050 |
Why?
|
| Sarcoma | 1 | 2014 | 1801 | 0.050 |
Why?
|
| Software | 1 | 2017 | 4434 | 0.050 |
Why?
|
| Immunoblotting | 3 | 2017 | 1646 | 0.050 |
Why?
|
| Medulla Oblongata | 1 | 2004 | 248 | 0.050 |
Why?
|
| Nippostrongylus | 1 | 2002 | 21 | 0.050 |
Why?
|
| Murine Acquired Immunodeficiency Syndrome | 1 | 2002 | 5 | 0.050 |
Why?
|
| Drug Therapy, Combination | 3 | 2022 | 6312 | 0.050 |
Why?
|
| STAT1 Transcription Factor | 1 | 2024 | 341 | 0.050 |
Why?
|
| Virus Inactivation | 1 | 2022 | 20 | 0.050 |
Why?
|
| STAT Transcription Factors | 1 | 2023 | 188 | 0.050 |
Why?
|
| Influenza, Human | 1 | 2014 | 1521 | 0.050 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 615 | 0.050 |
Why?
|
| Candidiasis | 2 | 2002 | 365 | 0.050 |
Why?
|
| Integrins | 3 | 1996 | 834 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2019 | 6485 | 0.050 |
Why?
|
| Mutation | 14 | 2023 | 30054 | 0.050 |
Why?
|
| Candida albicans | 2 | 2002 | 372 | 0.050 |
Why?
|
| Pyruvate Carboxylase | 1 | 2022 | 17 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2024 | 1363 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 2 | 2001 | 420 | 0.050 |
Why?
|
| Leukemia Virus, Murine | 1 | 2002 | 94 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2023 | 248 | 0.050 |
Why?
|
| Ultraviolet Rays | 2 | 2005 | 1080 | 0.050 |
Why?
|
| Animals, Newborn | 4 | 2009 | 2677 | 0.050 |
Why?
|
| GATA6 Transcription Factor | 1 | 2022 | 50 | 0.050 |
Why?
|
| Litter Size | 2 | 2013 | 49 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2020 | 2803 | 0.050 |
Why?
|
| Brain | 3 | 2009 | 27120 | 0.050 |
Why?
|
| Proto-Oncogenes | 2 | 1996 | 321 | 0.050 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2022 | 72 | 0.050 |
Why?
|
| Breast Neoplasms | 2 | 2020 | 21017 | 0.050 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2017 | 789 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2017 | 2490 | 0.050 |
Why?
|
| Tissue Donors | 3 | 2007 | 2332 | 0.050 |
Why?
|
| COS Cells | 3 | 2013 | 1130 | 0.050 |
Why?
|
| Neutrophils | 5 | 2021 | 3767 | 0.050 |
Why?
|
| Sheep | 1 | 2004 | 1440 | 0.050 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2024 | 502 | 0.050 |
Why?
|
| Glycerol | 1 | 2023 | 274 | 0.050 |
Why?
|
| Antibodies | 3 | 2013 | 2418 | 0.050 |
Why?
|
| Minor Histocompatibility Antigens | 2 | 2013 | 293 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2020 | 1115 | 0.050 |
Why?
|
| In Situ Hybridization | 3 | 1996 | 1900 | 0.050 |
Why?
|
| Succinic Acid | 1 | 2022 | 86 | 0.050 |
Why?
|
| Hair Follicle | 1 | 2024 | 211 | 0.050 |
Why?
|
| Immunologic Factors | 1 | 2011 | 1589 | 0.050 |
Why?
|
| HIV Infections | 2 | 2015 | 17352 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2022 | 411 | 0.050 |
Why?
|
| 3T3 Cells | 2 | 1999 | 1085 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2005 | 1406 | 0.050 |
Why?
|
| Mice, Inbred DBA | 3 | 1999 | 621 | 0.050 |
Why?
|
| Losartan | 1 | 2023 | 265 | 0.050 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2002 | 283 | 0.050 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2005 | 549 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2002 | 319 | 0.050 |
Why?
|
| RNA, Double-Stranded | 2 | 2018 | 294 | 0.050 |
Why?
|
| Pigmentation | 2 | 1991 | 144 | 0.050 |
Why?
|
| Toxoplasma | 1 | 2022 | 157 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2004 | 790 | 0.050 |
Why?
|
| Cell Compartmentation | 1 | 2021 | 384 | 0.050 |
Why?
|
| Glycolysis | 2 | 2016 | 835 | 0.050 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2020 | 81 | 0.050 |
Why?
|
| S Phase | 1 | 2002 | 421 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 2644 | 0.040 |
Why?
|
| G1 Phase | 1 | 2002 | 403 | 0.040 |
Why?
|
| Exotoxins | 1 | 1980 | 121 | 0.040 |
Why?
|
| Cycloheximide | 1 | 1980 | 343 | 0.040 |
Why?
|
| Rats, Long-Evans | 1 | 2001 | 383 | 0.040 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2022 | 302 | 0.040 |
Why?
|
| Fetal Death | 3 | 1997 | 435 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 1612 | 0.040 |
Why?
|
| Macrophage-1 Antigen | 2 | 2002 | 285 | 0.040 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2000 | 321 | 0.040 |
Why?
|
| Stem Cell Niche | 1 | 2024 | 345 | 0.040 |
Why?
|
| Chromosome Deletion | 2 | 2020 | 1386 | 0.040 |
Why?
|
| Obesity | 2 | 2020 | 12947 | 0.040 |
Why?
|
| Pyrimidinones | 1 | 2023 | 385 | 0.040 |
Why?
|
| Hemagglutinins, Viral | 1 | 1980 | 66 | 0.040 |
Why?
|
| Neoplasm Transplantation | 3 | 2015 | 2016 | 0.040 |
Why?
|
| Cell Cycle Proteins | 2 | 2002 | 3449 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 641 | 0.040 |
Why?
|
| Contractile Proteins | 1 | 2001 | 240 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 3 | 1997 | 4513 | 0.040 |
Why?
|
| Diphtheria Toxin | 1 | 1980 | 253 | 0.040 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 2 | 2005 | 377 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 1055 | 0.040 |
Why?
|
| Cyclins | 1 | 2002 | 594 | 0.040 |
Why?
|
| Genes, env | 1 | 1999 | 95 | 0.040 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 1999 | 107 | 0.040 |
Why?
|
| Fatty Acids | 2 | 2020 | 1808 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 1998 | 347 | 0.040 |
Why?
|
| Phosphates | 1 | 2023 | 770 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2010 | 3615 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 4 | 1997 | 6075 | 0.040 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2019 | 98 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2024 | 1069 | 0.040 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 2000 | 914 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2000 | 215 | 0.040 |
Why?
|
| Pyroglyphidae | 1 | 2019 | 89 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2020 | 6484 | 0.040 |
Why?
|
| Blotting, Northern | 3 | 1999 | 1545 | 0.040 |
Why?
|
| Viremia | 2 | 2013 | 707 | 0.040 |
Why?
|
| Forelimb | 1 | 1999 | 116 | 0.040 |
Why?
|
| Jurkat Cells | 2 | 2016 | 740 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2020 | 367 | 0.040 |
Why?
|
| NAD | 1 | 2023 | 614 | 0.040 |
Why?
|
| Neural Crest | 2 | 1991 | 279 | 0.040 |
Why?
|
| Antibodies, Viral | 3 | 2017 | 3156 | 0.040 |
Why?
|
| Cattle | 1 | 2004 | 3849 | 0.040 |
Why?
|
| Polysaccharides | 1 | 2005 | 1014 | 0.040 |
Why?
|
| Isoantigens | 1 | 2001 | 551 | 0.040 |
Why?
|
| Hematopoiesis | 3 | 1997 | 2050 | 0.040 |
Why?
|
| Blood Cells | 2 | 2017 | 305 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 2 | 1995 | 1601 | 0.040 |
Why?
|
| Edema | 1 | 2023 | 766 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2007 | 2180 | 0.040 |
Why?
|
| Vaccinia virus | 1 | 2000 | 331 | 0.040 |
Why?
|
| Immunoglobulin Fc Fragments | 2 | 1999 | 280 | 0.040 |
Why?
|
| Interleukin-5 | 2 | 2015 | 269 | 0.040 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2020 | 305 | 0.040 |
Why?
|
| Genes, Lethal | 2 | 1996 | 223 | 0.040 |
Why?
|
| Fibrosis | 1 | 2005 | 2049 | 0.040 |
Why?
|
| England | 1 | 2019 | 526 | 0.040 |
Why?
|
| Thymidine Kinase | 1 | 2018 | 286 | 0.040 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2002 | 655 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2020 | 535 | 0.040 |
Why?
|
| Scleroderma, Localized | 1 | 2019 | 87 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 5315 | 0.040 |
Why?
|
| DNA Mismatch Repair | 1 | 2021 | 428 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2000 | 457 | 0.040 |
Why?
|
| Digestive System | 1 | 1999 | 244 | 0.040 |
Why?
|
| Knowledge | 1 | 2019 | 177 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2004 | 1509 | 0.040 |
Why?
|
| Vaccines, Conjugate | 1 | 1999 | 328 | 0.040 |
Why?
|
| Streptococcus agalactiae | 1 | 1999 | 337 | 0.040 |
Why?
|
| Histocompatibility Antigens | 1 | 1999 | 464 | 0.040 |
Why?
|
| Yellow fever virus | 1 | 2017 | 23 | 0.040 |
Why?
|
| Lymphocyte Subsets | 1 | 2019 | 309 | 0.040 |
Why?
|
| Genes, MHC Class II | 2 | 2012 | 434 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 2 | 2013 | 2065 | 0.040 |
Why?
|
| Glucose | 3 | 2019 | 4346 | 0.040 |
Why?
|
| Factor VIII | 1 | 2000 | 348 | 0.040 |
Why?
|
| Adipose Tissue | 2 | 2019 | 3312 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2005 | 4021 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 1246 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 945 | 0.040 |
Why?
|
| Blood Platelets | 2 | 2001 | 2479 | 0.040 |
Why?
|
| Receptors, Cytokine | 2 | 2012 | 258 | 0.040 |
Why?
|
| Microinjections | 3 | 1993 | 321 | 0.040 |
Why?
|
| Lymphangiogenesis | 1 | 2018 | 172 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 1996 | 2112 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2017 | 3603 | 0.040 |
Why?
|
| Survival Analysis | 3 | 2021 | 10090 | 0.040 |
Why?
|
| Pyridones | 1 | 2023 | 809 | 0.040 |
Why?
|
| AIDS Vaccines | 2 | 2000 | 896 | 0.040 |
Why?
|
| Kinetics | 3 | 2020 | 6374 | 0.040 |
Why?
|
| Lymphatic System | 1 | 2018 | 254 | 0.040 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2003 | 740 | 0.040 |
Why?
|
| Freund's Adjuvant | 1 | 1997 | 149 | 0.030 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2020 | 455 | 0.030 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2000 | 537 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2022 | 1139 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2003 | 5799 | 0.030 |
Why?
|
| Lymphopoiesis | 1 | 2017 | 133 | 0.030 |
Why?
|
| Hindlimb | 1 | 1999 | 513 | 0.030 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1989 | 2151 | 0.030 |
Why?
|
| Cytoplasmic Granules | 1 | 1999 | 574 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2011 | 1705 | 0.030 |
Why?
|
| Polysaccharides, Bacterial | 1 | 1999 | 578 | 0.030 |
Why?
|
| Glycosylation | 1 | 2000 | 1097 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2007 | 2091 | 0.030 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2016 | 43 | 0.030 |
Why?
|
| Milk | 2 | 1990 | 443 | 0.030 |
Why?
|
| Ikaros Transcription Factor | 2 | 1996 | 232 | 0.030 |
Why?
|
| Granuloma | 1 | 1999 | 328 | 0.030 |
Why?
|
| Intestines | 3 | 2013 | 1909 | 0.030 |
Why?
|
| Angiomyolipoma | 1 | 2018 | 187 | 0.030 |
Why?
|
| Arabidopsis Proteins | 1 | 1998 | 264 | 0.030 |
Why?
|
| Vidarabine | 1 | 1998 | 336 | 0.030 |
Why?
|
| Hemophilia A | 1 | 2000 | 360 | 0.030 |
Why?
|
| Kidney Glomerulus | 3 | 2011 | 568 | 0.030 |
Why?
|
| Pregnancy | 11 | 2013 | 29876 | 0.030 |
Why?
|
| Societies, Scientific | 1 | 2017 | 222 | 0.030 |
Why?
|
| Peroxides | 1 | 2016 | 74 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1997 | 322 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2001 | 721 | 0.030 |
Why?
|
| Inflammasomes | 1 | 2021 | 526 | 0.030 |
Why?
|
| Genes, ras | 2 | 1989 | 654 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2021 | 842 | 0.030 |
Why?
|
| Epithelium | 2 | 1999 | 1603 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2020 | 1416 | 0.030 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2018 | 201 | 0.030 |
Why?
|
| Tissue Embedding | 1 | 2015 | 42 | 0.030 |
Why?
|
| Radiation Chimera | 2 | 2008 | 216 | 0.030 |
Why?
|
| Parasitemia | 1 | 2016 | 165 | 0.030 |
Why?
|
| Perineum | 1 | 2017 | 208 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 1995 | 691 | 0.030 |
Why?
|
| Harmine | 1 | 2015 | 11 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 682 | 0.030 |
Why?
|
| Cytarabine | 1 | 1998 | 698 | 0.030 |
Why?
|
| Reactive Oxygen Species | 2 | 2021 | 2141 | 0.030 |
Why?
|
| Hygromycin B | 1 | 1995 | 11 | 0.030 |
Why?
|
| Pliability | 1 | 2015 | 59 | 0.030 |
Why?
|
| Insulin Resistance | 2 | 2019 | 3963 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2001 | 1134 | 0.030 |
Why?
|
| Skin | 5 | 2017 | 4484 | 0.030 |
Why?
|
| Plasmids | 1 | 2000 | 2269 | 0.030 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1995 | 74 | 0.030 |
Why?
|
| Lymphoma | 1 | 2005 | 1901 | 0.030 |
Why?
|
| Ascitic Fluid | 1 | 1995 | 189 | 0.030 |
Why?
|
| Receptors, Chemokine | 2 | 2012 | 652 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2000 | 1062 | 0.030 |
Why?
|
| Adamantane | 1 | 2016 | 148 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 1486 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2018 | 64684 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 1997 | 1157 | 0.030 |
Why?
|
| Escherichia coli Proteins | 1 | 2002 | 1067 | 0.030 |
Why?
|
| Quality of Life | 1 | 2017 | 13367 | 0.030 |
Why?
|
| Thymoma | 1 | 1997 | 188 | 0.030 |
Why?
|
| Kidney | 4 | 2004 | 7047 | 0.030 |
Why?
|
| Allantois | 1 | 1995 | 33 | 0.030 |
Why?
|
| Receptors, LDL | 2 | 2011 | 488 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 234 | 0.030 |
Why?
|
| Mice, Inbred AKR | 1 | 1994 | 104 | 0.030 |
Why?
|
| Cinnamates | 1 | 1995 | 59 | 0.030 |
Why?
|
| Amino Acids | 1 | 2021 | 1718 | 0.030 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1995 | 141 | 0.030 |
Why?
|
| Integrin alpha4beta1 | 1 | 1995 | 119 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 634 | 0.030 |
Why?
|
| Proteomics | 2 | 2020 | 3848 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2003 | 1457 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 2015 | 311 | 0.030 |
Why?
|
| Arabidopsis | 1 | 1998 | 465 | 0.030 |
Why?
|
| Chorion | 1 | 1995 | 114 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2022 | 3713 | 0.030 |
Why?
|
| Reaction Time | 1 | 2001 | 2089 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 12148 | 0.030 |
Why?
|
| Genomic Library | 1 | 1994 | 189 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 1987 | 2518 | 0.030 |
Why?
|
| Body Patterning | 1 | 1999 | 632 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2000 | 1035 | 0.030 |
Why?
|
| Th1-Th2 Balance | 1 | 2014 | 38 | 0.030 |
Why?
|
| Calcium | 3 | 2017 | 5722 | 0.030 |
Why?
|
| Gelsolin | 1 | 1995 | 189 | 0.030 |
Why?
|
| Chimera | 2 | 1997 | 453 | 0.030 |
Why?
|
| Skull | 1 | 1999 | 818 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 3 | 2012 | 5790 | 0.030 |
Why?
|
| Nitric Oxide | 2 | 2019 | 2135 | 0.030 |
Why?
|
| Eosinophils | 2 | 2014 | 950 | 0.030 |
Why?
|
| Lymphatic Vessels | 1 | 2018 | 358 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2017 | 855 | 0.030 |
Why?
|
| Antibodies, Antinuclear | 3 | 2000 | 343 | 0.030 |
Why?
|
| Survival Rate | 3 | 2020 | 12725 | 0.030 |
Why?
|
| Thymus Neoplasms | 1 | 1997 | 274 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 1 | 2015 | 265 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 1999 | 1023 | 0.030 |
Why?
|
| Colitis, Ulcerative | 1 | 2006 | 1922 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2015 | 1541 | 0.030 |
Why?
|
| STAT4 Transcription Factor | 2 | 2004 | 93 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 1996 | 413 | 0.030 |
Why?
|
| Dermis | 1 | 2015 | 202 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 3778 | 0.030 |
Why?
|
| Peer Group | 1 | 2019 | 692 | 0.030 |
Why?
|
| Pyrimidines | 2 | 2016 | 3028 | 0.030 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2015 | 253 | 0.030 |
Why?
|
| Immunocompetence | 1 | 2014 | 138 | 0.030 |
Why?
|
| Cats | 1 | 2015 | 975 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 2000 | 1569 | 0.030 |
Why?
|
| Hybridomas | 2 | 1985 | 442 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2020 | 1321 | 0.030 |
Why?
|
| Nephritis | 2 | 2007 | 145 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 1999 | 1469 | 0.030 |
Why?
|
| Interferons | 1 | 2017 | 706 | 0.030 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2013 | 57 | 0.030 |
Why?
|
| Umbilical Cord | 1 | 1995 | 177 | 0.030 |
Why?
|
| Antibodies, Protozoan | 1 | 2014 | 252 | 0.030 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2013 | 340 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 3 | 2009 | 4740 | 0.030 |
Why?
|
| Embryo Loss | 1 | 2013 | 55 | 0.030 |
Why?
|
| Glutamine | 1 | 2016 | 577 | 0.030 |
Why?
|
| Life Expectancy | 1 | 2000 | 1242 | 0.030 |
Why?
|
| Vaccination | 3 | 2000 | 3384 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1994 | 1302 | 0.030 |
Why?
|
| Pan troglodytes | 1 | 2013 | 223 | 0.030 |
Why?
|
| Rats | 2 | 2001 | 23741 | 0.030 |
Why?
|
| Electrodes | 1 | 2015 | 614 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1995 | 416 | 0.030 |
Why?
|
| Animals, Wild | 1 | 1993 | 78 | 0.030 |
Why?
|
| beta-Thalassemia | 1 | 1995 | 236 | 0.030 |
Why?
|
| Antibody Specificity | 3 | 2003 | 1060 | 0.030 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2013 | 141 | 0.030 |
Why?
|
| Receptor Aggregation | 1 | 2012 | 72 | 0.030 |
Why?
|
| Microscopy, Video | 1 | 2013 | 241 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 1994 | 296 | 0.030 |
Why?
|
| Hypercholesterolemia | 2 | 2011 | 1141 | 0.030 |
Why?
|
| Aged | 6 | 2022 | 169310 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2014 | 343 | 0.030 |
Why?
|
| Mast Cells | 1 | 1999 | 1392 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 2 | 2003 | 413 | 0.020 |
Why?
|
| Respiration | 1 | 2018 | 1657 | 0.020 |
Why?
|
| Heparin | 1 | 1999 | 1634 | 0.020 |
Why?
|
| Bystander Effect | 1 | 2012 | 90 | 0.020 |
Why?
|
| Gastric Mucosa | 1 | 2015 | 604 | 0.020 |
Why?
|
| Lentivirus | 1 | 2014 | 508 | 0.020 |
Why?
|
| Antigens, Ly | 1 | 2013 | 295 | 0.020 |
Why?
|
| Interferon-beta | 1 | 2013 | 345 | 0.020 |
Why?
|
| DNA, Viral | 2 | 1996 | 2202 | 0.020 |
Why?
|
| Monophenol Monooxygenase | 1 | 1991 | 72 | 0.020 |
Why?
|
| Cornea | 2 | 2011 | 1333 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 2014 | 412 | 0.020 |
Why?
|
| Binding, Competitive | 2 | 2000 | 1141 | 0.020 |
Why?
|
| Respiratory System | 1 | 2015 | 563 | 0.020 |
Why?
|
| Helicobacter Infections | 1 | 2015 | 388 | 0.020 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2011 | 30 | 0.020 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2012 | 100 | 0.020 |
Why?
|
| Nerve Degeneration | 2 | 1999 | 748 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2015 | 1085 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2013 | 496 | 0.020 |
Why?
|
| Gestational Age | 2 | 1993 | 3577 | 0.020 |
Why?
|
| Myelin Proteolipid Protein | 2 | 2002 | 107 | 0.020 |
Why?
|
| Skin Transplantation | 2 | 2011 | 1083 | 0.020 |
Why?
|
| Injections, Subcutaneous | 2 | 2003 | 681 | 0.020 |
Why?
|
| Lymphokines | 2 | 2007 | 927 | 0.020 |
Why?
|
| Binding Sites | 2 | 2012 | 6056 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2022 | 9280 | 0.020 |
Why?
|
| Abdomen | 1 | 2017 | 1128 | 0.020 |
Why?
|
| Triazoles | 1 | 2016 | 903 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2015 | 757 | 0.020 |
Why?
|
| DNA Damage | 1 | 2021 | 2449 | 0.020 |
Why?
|
| Necrosis | 2 | 2010 | 1611 | 0.020 |
Why?
|
| Interleukin-1alpha | 1 | 2011 | 86 | 0.020 |
Why?
|
| Orthopedics | 1 | 2019 | 898 | 0.020 |
Why?
|
| Vimentin | 2 | 1982 | 255 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 384 | 0.020 |
Why?
|
| Restriction Mapping | 3 | 1998 | 851 | 0.020 |
Why?
|
| Adiposity | 1 | 2020 | 1879 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2012 | 517 | 0.020 |
Why?
|
| Neutralization Tests | 2 | 1984 | 728 | 0.020 |
Why?
|
| Acetylation | 1 | 2013 | 1055 | 0.020 |
Why?
|
| Disease Progression | 3 | 2021 | 13510 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2012 | 453 | 0.020 |
Why?
|
| Electroretinography | 1 | 2012 | 525 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2013 | 365 | 0.020 |
Why?
|
| Fluorophotometry | 1 | 2009 | 40 | 0.020 |
Why?
|
| Proteinuria | 2 | 2005 | 607 | 0.020 |
Why?
|
| Learning | 1 | 2019 | 1740 | 0.020 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1990 | 154 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1999 | 2448 | 0.020 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2011 | 233 | 0.020 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 2 | 2000 | 75 | 0.020 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 3 | 1997 | 359 | 0.020 |
Why?
|
| Pertussis Toxin | 1 | 1990 | 176 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2021 | 3113 | 0.020 |
Why?
|
| Cell Transplantation | 1 | 2011 | 472 | 0.020 |
Why?
|
| Neurons, Afferent | 1 | 1992 | 498 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2000 | 2917 | 0.020 |
Why?
|
| Antimalarials | 1 | 2016 | 907 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2011 | 779 | 0.020 |
Why?
|
| Gene Products, env | 1 | 1990 | 250 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 2011 | 510 | 0.020 |
Why?
|
| Galactosylceramides | 1 | 2009 | 92 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 12975 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2016 | 1844 | 0.020 |
Why?
|
| Demyelinating Diseases | 1 | 2011 | 351 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2016 | 2707 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 39107 | 0.020 |
Why?
|
| Retinol-Binding Proteins | 1 | 2009 | 67 | 0.020 |
Why?
|
| Cricetulus | 1 | 2011 | 814 | 0.020 |
Why?
|
| Optic Nerve | 1 | 2012 | 572 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2013 | 1529 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1998 | 1551 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 3792 | 0.020 |
Why?
|
| Models, Biological | 1 | 1985 | 9469 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 2011 | 623 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2009 | 427 | 0.020 |
Why?
|
| Aerosols | 1 | 2010 | 635 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2014 | 933 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 4915 | 0.020 |
Why?
|
| Erythropoiesis | 3 | 1996 | 683 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 2011 | 642 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 1971 | 0.020 |
Why?
|
| Egg Proteins | 1 | 2007 | 57 | 0.020 |
Why?
|
| Rabbits | 1 | 2014 | 4772 | 0.020 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 1990 | 335 | 0.020 |
Why?
|
| Time Factors | 6 | 2011 | 39970 | 0.020 |
Why?
|
| Genotype | 4 | 2011 | 12990 | 0.020 |
Why?
|
| Epithelium, Corneal | 1 | 2009 | 253 | 0.020 |
Why?
|
| Cholesterol | 2 | 2007 | 2904 | 0.020 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2010 | 651 | 0.020 |
Why?
|
| Chromosomes, Mammalian | 1 | 2007 | 147 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2012 | 1206 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 1990 | 755 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2019 | 9646 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2020 | 80646 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 5672 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2012 | 1154 | 0.020 |
Why?
|
| Lipopolysaccharides | 2 | 2004 | 2206 | 0.020 |
Why?
|
| Middle Aged | 5 | 2020 | 220920 | 0.020 |
Why?
|
| Hepacivirus | 1 | 2013 | 1336 | 0.020 |
Why?
|
| Microcirculation | 1 | 2011 | 1272 | 0.020 |
Why?
|
| Genes | 1 | 1990 | 1823 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2007 | 670 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2850 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2000 | 3733 | 0.020 |
Why?
|
| Indoles | 1 | 2014 | 1833 | 0.020 |
Why?
|
| Major Histocompatibility Complex | 1 | 2008 | 870 | 0.020 |
Why?
|
| Blood Urea Nitrogen | 1 | 2005 | 186 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 695 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 3430 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2018 | 2223 | 0.020 |
Why?
|
| Adenomatosis, Pulmonary | 1 | 2005 | 1 | 0.020 |
Why?
|
| Eye Proteins | 1 | 2009 | 633 | 0.020 |
Why?
|
| 4-1BB Ligand | 1 | 2004 | 29 | 0.020 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1984 | 52 | 0.020 |
Why?
|
| Adult | 5 | 2020 | 221203 | 0.020 |
Why?
|
| Adenine | 1 | 1991 | 987 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 1835 | 0.020 |
Why?
|
| Integrin alpha3 | 1 | 2004 | 26 | 0.010 |
Why?
|
| Clone Cells | 3 | 1996 | 1659 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2010 | 2571 | 0.010 |
Why?
|
| Oxygen | 1 | 2016 | 4227 | 0.010 |
Why?
|
| Zinc Fingers | 2 | 1998 | 579 | 0.010 |
Why?
|
| Axons | 1 | 2012 | 1674 | 0.010 |
Why?
|
| Biopsy | 1 | 2016 | 6766 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2014 | 1978 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 58986 | 0.010 |
Why?
|
| Chaperonin 60 | 1 | 2004 | 97 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 473 | 0.010 |
Why?
|
| Deoxyribonuclease I | 1 | 2004 | 224 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 477 | 0.010 |
Why?
|
| Myocardium | 2 | 2011 | 4725 | 0.010 |
Why?
|
| Haplotypes | 1 | 2009 | 2713 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2005 | 15633 | 0.010 |
Why?
|
| Enzyme Reactivators | 1 | 2002 | 6 | 0.010 |
Why?
|
| Biological Therapy | 1 | 2004 | 141 | 0.010 |
Why?
|
| Cell Migration Inhibition | 1 | 2002 | 97 | 0.010 |
Why?
|
| Antibodies, Helminth | 1 | 2002 | 57 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 2003 | 216 | 0.010 |
Why?
|
| Inclusion Bodies, Viral | 1 | 1982 | 45 | 0.010 |
Why?
|
| Integrin alphaXbeta2 | 1 | 2002 | 29 | 0.010 |
Why?
|
| Receptors, CXCR5 | 1 | 2003 | 88 | 0.010 |
Why?
|
| Actins | 2 | 2004 | 2050 | 0.010 |
Why?
|
| Parasite Egg Count | 1 | 2002 | 29 | 0.010 |
Why?
|
| IgG Deficiency | 1 | 2002 | 28 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 2004 | 6534 | 0.010 |
Why?
|
| Canada | 1 | 2008 | 2122 | 0.010 |
Why?
|
| Hyperplasia | 2 | 2000 | 1152 | 0.010 |
Why?
|
| Organ Transplantation | 1 | 2012 | 1157 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 1984 | 616 | 0.010 |
Why?
|
| Intestinal Diseases | 1 | 1987 | 504 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1990 | 1819 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2014 | 3677 | 0.010 |
Why?
|
| Mutagenesis | 2 | 1996 | 1232 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2005 | 1791 | 0.010 |
Why?
|
| Collagen | 1 | 1990 | 2638 | 0.010 |
Why?
|
| Lymphocytosis | 1 | 2002 | 121 | 0.010 |
Why?
|
| Young Adult | 2 | 2019 | 59255 | 0.010 |
Why?
|
| Profilins | 1 | 2001 | 65 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 2003 | 422 | 0.010 |
Why?
|
| Isoantibodies | 1 | 2005 | 674 | 0.010 |
Why?
|
| Terbutaline | 1 | 2000 | 23 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11121 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 441 | 0.010 |
Why?
|
| 4-Nitroquinoline-1-oxide | 1 | 2000 | 17 | 0.010 |
Why?
|
| Host-Parasite Interactions | 1 | 2003 | 300 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 579 | 0.010 |
Why?
|
| Otitis Media, Suppurative | 1 | 2000 | 27 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 8002 | 0.010 |
Why?
|
| Homozygote | 2 | 1999 | 1776 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 2000 | 114 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2000 | 96 | 0.010 |
Why?
|
| RecQ Helicases | 1 | 2000 | 53 | 0.010 |
Why?
|
| Methionine | 1 | 1982 | 572 | 0.010 |
Why?
|
| Lymphopenia | 1 | 2002 | 281 | 0.010 |
Why?
|
| Pedigree | 1 | 2008 | 4542 | 0.010 |
Why?
|
| Ependyma | 1 | 1980 | 56 | 0.010 |
Why?
|
| Carboxypeptidases A | 1 | 1999 | 37 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2000 | 317 | 0.010 |
Why?
|
| Trichinellosis | 1 | 1999 | 27 | 0.010 |
Why?
|
| Trichinella spiralis | 1 | 1999 | 22 | 0.010 |
Why?
|
| Chymases | 1 | 1999 | 73 | 0.010 |
Why?
|
| Pheromones | 1 | 2000 | 93 | 0.010 |
Why?
|
| Aorta | 1 | 2007 | 2041 | 0.010 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2000 | 111 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2000 | 554 | 0.010 |
Why?
|
| Enzyme Precursors | 1 | 1999 | 170 | 0.010 |
Why?
|
| Carboxypeptidases | 1 | 1999 | 154 | 0.010 |
Why?
|
| Graft vs Tumor Effect | 1 | 1999 | 68 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1989 | 2827 | 0.010 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 1999 | 62 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2009 | 15936 | 0.010 |
Why?
|
| Mice, Nude | 2 | 1999 | 3614 | 0.010 |
Why?
|
| Sexual Behavior, Animal | 1 | 2000 | 120 | 0.010 |
Why?
|
| Poisson Distribution | 1 | 2000 | 504 | 0.010 |
Why?
|
| Oxazolone | 1 | 1998 | 61 | 0.010 |
Why?
|
| Limb Buds | 1 | 1999 | 76 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1999 | 240 | 0.010 |
Why?
|
| Exodeoxyribonucleases | 1 | 2000 | 192 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2005 | 3088 | 0.010 |
Why?
|
| Sulfotransferases | 1 | 1999 | 150 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2007 | 1886 | 0.010 |
Why?
|
| Child | 2 | 2005 | 80156 | 0.010 |
Why?
|
| Amidohydrolases | 1 | 1999 | 159 | 0.010 |
Why?
|
| Complement C3 | 1 | 2000 | 435 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41493 | 0.010 |
Why?
|
| Plants, Genetically Modified | 1 | 1998 | 115 | 0.010 |
Why?
|
| Arabinofuranosylcytosine Triphosphate | 1 | 1998 | 7 | 0.010 |
Why?
|
| Tryptases | 1 | 1999 | 176 | 0.010 |
Why?
|
| Sulfates | 1 | 1999 | 380 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1999 | 1058 | 0.010 |
Why?
|
| Sequence Analysis, Protein | 1 | 1999 | 261 | 0.010 |
Why?
|
| Tromethamine | 1 | 1978 | 31 | 0.010 |
Why?
|
| Lymphocyte Transfusion | 1 | 1999 | 232 | 0.010 |
Why?
|
| Ovum | 1 | 1999 | 187 | 0.010 |
Why?
|
| Limb Deformities, Congenital | 1 | 1999 | 136 | 0.010 |
Why?
|
| Blastocyst | 1 | 2001 | 433 | 0.010 |
Why?
|
| Neck | 1 | 2003 | 734 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1997 | 113 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 2416 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1998 | 555 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 1999 | 410 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1999 | 817 | 0.010 |
Why?
|
| Receptors, IgG | 1 | 2000 | 559 | 0.010 |
Why?
|
| Bacterial Vaccines | 1 | 1999 | 401 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1999 | 783 | 0.010 |
Why?
|
| Jejunum | 1 | 1999 | 472 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 2000 | 400 | 0.010 |
Why?
|
| Serotyping | 1 | 1978 | 325 | 0.010 |
Why?
|
| Gene Library | 1 | 2000 | 1059 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2000 | 1178 | 0.010 |
Why?
|
| Thioglycolates | 1 | 1996 | 37 | 0.010 |
Why?
|
| Point Mutation | 1 | 2002 | 1595 | 0.010 |
Why?
|
| Yolk Sac | 1 | 1997 | 79 | 0.010 |
Why?
|
| Core Binding Factor beta Subunit | 1 | 1996 | 42 | 0.010 |
Why?
|
| Opsonin Proteins | 1 | 1996 | 144 | 0.010 |
Why?
|
| Algorithms | 1 | 2017 | 14032 | 0.010 |
Why?
|
| DNA, Plant | 1 | 1996 | 52 | 0.010 |
Why?
|
| Chloroplasts | 1 | 1996 | 46 | 0.010 |
Why?
|
| Quinolones | 1 | 2000 | 378 | 0.010 |
Why?
|
| Respiratory Burst | 1 | 1996 | 110 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1997 | 228 | 0.010 |
Why?
|
| Nervous System | 1 | 2000 | 545 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2002 | 3597 | 0.010 |
Why?
|
| Transcription Factor AP-2 | 1 | 1996 | 80 | 0.010 |
Why?
|
| Neurons | 2 | 1990 | 9463 | 0.010 |
Why?
|
| Camptothecin | 1 | 2000 | 591 | 0.010 |
Why?
|
| Craniofacial Abnormalities | 1 | 1999 | 319 | 0.010 |
Why?
|
| Acetates | 1 | 1978 | 321 | 0.010 |
Why?
|
| Epidermis | 1 | 1999 | 528 | 0.010 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 1996 | 77 | 0.010 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1996 | 173 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1996 | 397 | 0.010 |
Why?
|
| Virion | 1 | 1978 | 422 | 0.010 |
Why?
|
| Janus Kinase 3 | 1 | 1995 | 76 | 0.010 |
Why?
|
| Egg Yolk | 1 | 1995 | 24 | 0.010 |
Why?
|
| Genes, Switch | 1 | 1995 | 48 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1996 | 532 | 0.010 |
Why?
|
| Ion Channels | 1 | 2000 | 1040 | 0.010 |
Why?
|
| Fetus | 2 | 1995 | 1863 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1978 | 1741 | 0.010 |
Why?
|
| Eosinophilia | 1 | 2000 | 560 | 0.010 |
Why?
|
| Morphogenesis | 1 | 1999 | 741 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1997 | 453 | 0.010 |
Why?
|
| Diet | 1 | 2013 | 8075 | 0.010 |
Why?
|
| Integrin alpha4 | 1 | 1995 | 87 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 1995 | 315 | 0.010 |
Why?
|
| Allergens | 1 | 2002 | 1432 | 0.010 |
Why?
|
| Placentation | 1 | 1995 | 78 | 0.010 |
Why?
|
| Glycine | 1 | 1978 | 663 | 0.010 |
Why?
|
| Peritonitis | 1 | 1996 | 368 | 0.010 |
Why?
|
| Globins | 1 | 1995 | 404 | 0.010 |
Why?
|
| Hemorrhage | 2 | 1996 | 3424 | 0.010 |
Why?
|
| Fertility | 1 | 1999 | 771 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1999 | 1814 | 0.010 |
Why?
|
| Prediabetic State | 1 | 2000 | 545 | 0.010 |
Why?
|
| Leukemia, Myeloid | 1 | 1997 | 694 | 0.010 |
Why?
|
| Hydrocephalus | 1 | 2000 | 764 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 1999 | 867 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1978 | 1510 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1996 | 815 | 0.010 |
Why?
|
| Nucleotide Mapping | 1 | 1992 | 19 | 0.010 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1980 | 1277 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 2000 | 1423 | 0.010 |
Why?
|
| Hemostasis | 1 | 1995 | 467 | 0.010 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 1995 | 504 | 0.010 |
Why?
|
| Leptin | 1 | 2000 | 1597 | 0.010 |
Why?
|
| Gene Dosage | 1 | 1996 | 1218 | 0.010 |
Why?
|
| Rhinitis | 1 | 2000 | 747 | 0.010 |
Why?
|
| Leukocytes | 1 | 2000 | 2026 | 0.010 |
Why?
|
| Introns | 1 | 1995 | 981 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 20571 | 0.010 |
Why?
|
| Phylogeny | 1 | 1999 | 2811 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1996 | 2218 | 0.010 |
Why?
|
| Fetal Resorption | 1 | 1991 | 15 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1997 | 2510 | 0.010 |
Why?
|
| Viral Proteins | 1 | 1978 | 1804 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 1997 | 1393 | 0.010 |
Why?
|
| Molecular Probe Techniques | 1 | 1991 | 111 | 0.010 |
Why?
|
| Iris | 1 | 1992 | 232 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1997 | 2601 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1995 | 1596 | 0.010 |
Why?
|
| Salivary Glands | 1 | 1992 | 229 | 0.010 |
Why?
|
| Poly A | 1 | 1990 | 181 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 416 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2002 | 4217 | 0.010 |
Why?
|
| Endocytosis | 2 | 1987 | 957 | 0.010 |
Why?
|
| Procollagen | 1 | 1990 | 187 | 0.010 |
Why?
|
| Body Weight | 1 | 2000 | 4618 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1995 | 1596 | 0.010 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 1989 | 68 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1989 | 455 | 0.000 |
Why?
|
| Mosaicism | 1 | 1991 | 475 | 0.000 |
Why?
|
| Lactation | 1 | 1990 | 397 | 0.000 |
Why?
|
| Prevalence | 1 | 2005 | 15732 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1990 | 1434 | 0.000 |
Why?
|
| Hippocampus | 1 | 2000 | 3766 | 0.000 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1989 | 340 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1990 | 2561 | 0.000 |
Why?
|
| Brain Chemistry | 1 | 1990 | 960 | 0.000 |
Why?
|
| Milk, Human | 1 | 1990 | 486 | 0.000 |
Why?
|
| Anemia | 1 | 1995 | 1509 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 2000 | 4948 | 0.000 |
Why?
|
| Wound Healing | 1 | 1995 | 2805 | 0.000 |
Why?
|
| HIV-1 | 1 | 2000 | 6863 | 0.000 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1981 | 151 | 0.000 |
Why?
|
| Animals, Suckling | 1 | 1981 | 69 | 0.000 |
Why?
|
| Temperature | 2 | 1978 | 2226 | 0.000 |
Why?
|
| Gastrointestinal Diseases | 1 | 1990 | 1200 | 0.000 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 1999 | 5672 | 0.000 |
Why?
|
| Bone and Bones | 1 | 1990 | 2568 | 0.000 |
Why?
|
| Extracellular Space | 1 | 1981 | 563 | 0.000 |
Why?
|
| Genetic Code | 1 | 1978 | 138 | 0.000 |
Why?
|
| Heart Defects, Congenital | 1 | 1995 | 4671 | 0.000 |
Why?
|
| Kidney Failure, Chronic | 1 | 1990 | 2472 | 0.000 |
Why?
|
| Infant | 1 | 1998 | 36192 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1998 | 42230 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1989 | 4026 | 0.000 |
Why?
|
| Adolescent | 1 | 1998 | 88324 | 0.000 |
Why?
|